[1]
E. Akaho, “Development of Cyclic Tetrapeptide as an EGFR Tyrosine Kinase Inhibitor Assayed by ELISA Experiment and Docking Study: A Novel Approach”, CAPR-V2, pp. 108–121, Apr. 2022.